Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I R Judson

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Biochimica Et Biophysica Acta|December 3, 2014
Targeting protein kinase C in sarcomaJ Martin-Liberal, A J Cameron, J Claus, et al.
Biochemical Pharmacology|December 14, 1993
The in vivo metabolic stability of dipeptide analogues of the quinazoline antifolate, ICI 198583, in miceD I Jodrell, W Gibson, G M Bisset, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activationC J Rutty, I R Judson, G Abel, et al.
Biochemical Pharmacology|February 24, 1993
The measurement of polyglutamate metabolites of the thymidylate synthase inhibitor, ICI D1694, in mouse and human cultured cellsW Gibson, G M Bisset, P R Marsham, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2000
Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcomaH M Coley, M W Verrill, S E Gregson, et al.
Biochemical Pharmacology|May 11, 1995
The role of the N-(hydroxymethyl)melamines as antitumour agents: mechanism of action studiesH M Coley, N Brooks, D H Phillips, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2003
Increased tumour extracellular pH induced by Bafilomycin A1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokineticsP M J McSheehy, H Troy, L R Kelland, et al.
Journal of Inorganic Biochemistry|January 8, 2000
Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistanceL R Kelland, S Y Sharp, C F O'Neill, et al.
British Journal of Cancer|February 1, 1991
Phase II trial of trimelamol in refractory ovarian cancerI R Judson, A H Calvert, M E Gore, et al.
Journal of Medicinal Chemistry|December 24, 1993
Synthesis and cytotoxicity of potential tumor-inhibitory analogues of trimelamol (2,4,6-tris[(hydroxymethyl)methylamino]-1,3,5-triazine) having electron-withdrawing groups in place of methylM Jarman, H M Coley, I R Judson, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Biochimica Et Biophysica Acta|December 3, 2014
Targeting protein kinase C in sarcomaJ Martin-Liberal, A J Cameron, J Claus, et al.
Biochemical Pharmacology|December 14, 1993
The in vivo metabolic stability of dipeptide analogues of the quinazoline antifolate, ICI 198583, in miceD I Jodrell, W Gibson, G M Bisset, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activationC J Rutty, I R Judson, G Abel, et al.
Biochemical Pharmacology|February 24, 1993
The measurement of polyglutamate metabolites of the thymidylate synthase inhibitor, ICI D1694, in mouse and human cultured cellsW Gibson, G M Bisset, P R Marsham, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2000
Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcomaH M Coley, M W Verrill, S E Gregson, et al.
Biochemical Pharmacology|May 11, 1995
The role of the N-(hydroxymethyl)melamines as antitumour agents: mechanism of action studiesH M Coley, N Brooks, D H Phillips, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2003
Increased tumour extracellular pH induced by Bafilomycin A1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokineticsP M J McSheehy, H Troy, L R Kelland, et al.
Journal of Inorganic Biochemistry|January 8, 2000
Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistanceL R Kelland, S Y Sharp, C F O'Neill, et al.
British Journal of Cancer|February 1, 1991
Phase II trial of trimelamol in refractory ovarian cancerI R Judson, A H Calvert, M E Gore, et al.
Journal of Medicinal Chemistry|December 24, 1993
Synthesis and cytotoxicity of potential tumor-inhibitory analogues of trimelamol (2,4,6-tris[(hydroxymethyl)methylamino]-1,3,5-triazine) having electron-withdrawing groups in place of methylM Jarman, H M Coley, I R Judson, et al.
Pageof 7